Our assays provide instant and highly accurate results and our mobile tracking app delivers data in real-time so that immediate and informed decisions about care can be made. Patients can self-quarantine, communities are in the know, and health care decision makers can take actionable steps to contain potential epidemics.
We combine rapid and highly accurate test results, affordability, ease of use, and real-time monitoring and data sharing. The lab-made reagents we utilize come from immune cells (B cells) of mammals exposed to the disease and from humans or animal reservoirs early in the epidemic cycle. We use these novel recombinant molecules with high detection performance to pathogens.
Higher accuracy design with the added proprietary electric and magnetic properties of nanoparticles.
We are designing diagnostic technologies and deploying them for comprehensive, start to end solutions.
